{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T15:14:42Z","timestamp":1791126882734,"version":"4.1.0"},"reference-count":17,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"vor","delay-in-days":366,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["bjanaesthesia.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["British Journal of Anaesthesia"],"published-print":{"date-parts":[[2024,1]]},"DOI":"10.1016\/j.bja.2023.10.022","type":"journal-article","created":{"date-parts":[[2023,11,25]],"date-time":"2023-11-25T04:15:10Z","timestamp":1700885710000},"page":"45-52","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"title":["Phase III clinical trial comparing the efficacy and safety of adamgammadex with sugammadex for reversal of rocuronium-induced neuromuscular block"],"prefix":"10.1016","volume":"132","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0419-5397","authenticated-orcid":false,"given":"Yujun","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yingying","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8647-1011","authenticated-orcid":false,"given":"Qian","family":"Lei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chaoyu","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shu'an","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yidan","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yalan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Hong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shoushi","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Han","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yangwen","family":"Ou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaohua","family":"Zou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiang","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qulian","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8726-3107","authenticated-orcid":false,"given":"Zhigang","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Su","family":"Min","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Youmao","family":"Qi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qing","family":"Jie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bin","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2737-8623","authenticated-orcid":false,"given":"Wensheng","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bja.2023.10.022_bib1","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.jclinane.2017.06.006","article-title":"Sugammadex efficacy for reversal of rocuronium- and vecuronium-induced neuromuscular blockade: a pooled analysis of 26 studies","volume":"41","author":"Herring","year":"2017","journal-title":"J\u00a0Clin Anesth"},{"key":"10.1016\/j.bja.2023.10.022_bib2","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1111\/anae.12736","article-title":"Hypersensitivity associated with sugammadex administration: a systematic review","volume":"69","author":"Tsur","year":"2014","journal-title":"Anaesthesia"},{"key":"10.1016\/j.bja.2023.10.022_bib3","first-page":"1","article-title":"Allergic and other adverse reactions to drugs used in anesthesia and surgery","volume":"1","author":"Baldo","year":"2023","journal-title":"APS"},{"key":"10.1016\/j.bja.2023.10.022_bib4","first-page":"515","article-title":"Screened adamgammadex for reversing rocuronium-induced neuromuscular blockade with greater safety","volume":"32","author":"Qi","year":"2018","journal-title":"Chin J Pharmacol Toxicol"},{"key":"10.1016\/j.bja.2023.10.022_bib5","doi-asserted-by":"crossref","first-page":"507","DOI":"10.3724\/SP.J.1008.2015.00507","article-title":"Spectroscopy study on the interaction of \u03b3-cyclodextrin and its two derivatives with rocuronium and vecuronium","volume":"36","author":"Chen","year":"2015","journal-title":"Acad J Second Mil Med Univ"},{"key":"10.1016\/j.bja.2023.10.022_bib6","first-page":"266","article-title":"A\u00a0novel concept of reversing neuromuscular block: chemical encapsulation of rocuronium bromide by a cyclodextrin-based synthetic host","volume":"41","author":"Bom","year":"2002","journal-title":"Angew Chem Int Ed Engl"},{"key":"10.1016\/j.bja.2023.10.022_bib7","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejps.2019.105134","article-title":"Safety, tolerability, and pharmacokinetics of adamgammadex sodium, a novel agent to reverse the action of rocuronium and vecuronium, in healthy volunteers","volume":"141","author":"Jiang","year":"2020","journal-title":"Eur J Pharm Sci"},{"key":"10.1016\/j.bja.2023.10.022_bib8","first-page":"6951","article-title":"Comparison of the efficacy and safety of adamgammadex with sugammadex for reversal of rocuronium-induced neuromuscular block: results of a phase II clinical trial","volume":"11","author":"Jiang","year":"2022","journal-title":"J\u00a0Clin Med"},{"key":"10.1016\/j.bja.2023.10.022_bib9","article-title":"Efficiency and safety of the selective relaxant binding agent adamgammadex sodium for reversing rocuronium-induced deep neuromuscular block: a single-center, open-label, dose-finding, and phase IIa study","volume":"8","author":"Zhao","year":"2021","journal-title":"Front Med (Lausanne)"},{"key":"10.1016\/j.bja.2023.10.022_bib10","doi-asserted-by":"crossref","first-page":"3760","DOI":"10.1111\/bcp.15320","article-title":"Adamgammadex in patients to reverse a moderate rocuronium-induced neuromuscular block","volume":"88","author":"Jiang","year":"2022","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.bja.2023.10.022_bib11","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1097\/00000542-199704000-00005","article-title":"Relationship of the train-of-four fade ratio to clinical signs and symptoms of residual paralysis in awake volunteers","volume":"86","author":"Kopman","year":"1997","journal-title":"Anesthesiology"},{"key":"10.1016\/j.bja.2023.10.022_bib12","unstructured":"National Cancer Institute (US). Cancer Therapy Evaluation Program. Common Terminology Criteria for Adverse Events (CTCAE), v5.0. 2017. Available from https:\/\/ctep.cancer.gov\/protocolDevelopment\/electronic_applications\/ctc.htm#ctc_50."},{"key":"10.1016\/j.bja.2023.10.022_bib13","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1097\/ALN.0b013e3181f4182a","article-title":"Sugammadex and neostigmine dose-finding study for reversal of shallow residual neuromuscular block","volume":"113","author":"Schaller","year":"2010","journal-title":"Anesthesiology"},{"key":"10.1016\/j.bja.2023.10.022_bib14","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1186\/s12871-017-0348-9","article-title":"Half dose sugammadex combined with neostigmine is non-inferior to full dose sugammadex for reversal of rocuronium-induced deep neuromuscular blockade: a cost-saving strategy","volume":"17","author":"Aouad","year":"2017","journal-title":"BMC Anesthesiol"},{"key":"10.1016\/j.bja.2023.10.022_bib15","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1080\/14740338.2019.1649393","article-title":"Safety of sugammadex for reversal of neuromuscular block","volume":"18","author":"Honing","year":"2019","journal-title":"Expert Opin Drug Saf"},{"key":"10.1016\/j.bja.2023.10.022_bib16","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1111\/bcp.15417","article-title":"Safety of sugammadex for reversal of neuromuscular block: a postmarketing study based on the World Health Organization pharmacovigilance database","volume":"89","author":"Lyu","year":"2023","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.bja.2023.10.022_bib17","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1186\/s12871-017-0429-9","article-title":"Preparing for the unexpected: special considerations and complications after sugammadex administration","volume":"17","author":"Iwasaki","year":"2017","journal-title":"BMC Anesthesiol"}],"container-title":["British Journal of Anaesthesia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0007091223005779?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0007091223005779?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,13]],"date-time":"2025-09-13T19:06:33Z","timestamp":1757790393000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0007091223005779"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1]]},"references-count":17,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2024,1]]}},"alternative-id":["S0007091223005779"],"URL":"https:\/\/doi.org\/10.1016\/j.bja.2023.10.022","relation":{},"ISSN":["0007-0912"],"issn-type":[{"value":"0007-0912","type":"print"}],"subject":[],"published":{"date-parts":[[2024,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Phase III clinical trial comparing the efficacy and safety of adamgammadex with sugammadex for reversal of rocuronium-induced neuromuscular block","name":"articletitle","label":"Article Title"},{"value":"British Journal of Anaesthesia","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bja.2023.10.022","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 British Journal of Anaesthesia. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}